Jefferies Group’s Integra LifeSciences IART Stock Holding History

Jefferies Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$233K	Buy	5,511 +3,055	+124%	+$157K	﹤0.01%	1321
2022 Q2	$133K	Sell	2,456 -71,200	-97%	-$4.28M	﹤0.01%	1329
2022 Q1	$4.73M	Buy	+73,656	New	+$4.85M	0.03%	436
2021 Q3	–	Sell	-3,786	Closed	-$258K	–	1841
2021 Q2	$258K	Buy	+3,786	New	+$268K	﹤0.01%	1346
2020 Q2	–	Sell	-14,807	Closed	-$661K	–	1648
2020 Q1	$661K	Buy	14,807 +10,100	+215%	+$530K	0.01%	1208
2019 Q4	$274K	Buy	4,707 +1,327	+39%	+$79K	﹤0.01%	2101
2019 Q3	$203K	Buy	+3,380	New	+$201K	﹤0.01%	2358
2019 Q2	–	Sell	-17,835	Closed	-$994K	–	2676
2019 Q1	$994K	Buy	+17,835	New	+$908K	0.01%	1271
2018 Q3	–	Sell	-19,852	Closed	-$1.28M	–	2554
2018 Q2	$1.28M	Buy	+19,852	New	+$1.23M	0.01%	1120
2017 Q3	–	Sell	-5,478	Closed	-$299K	–	2463
2017 Q2	$299K	Buy	+5,478	New	+$262K	﹤0.01%	1866
2016 Q4	–	Sell	-5,114	Closed	-$211K	–	2322
2016 Q3	$211K	Buy	+5,114	New	+$214K	﹤0.01%	1924
2015 Q3	–	Sell	-3,868	Closed	-$107K	–	2617
2015 Q2	$107K	Buy	+3,868	New	+$103K	﹤0.01%	2190
2014 Q4	–	Sell	-10,175	Closed	-$206K	–	2118
2014 Q3	$206K	Buy	+10,175	New	+$203K	﹤0.01%	1796

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jefferies Group's IART Position: Q3 2022 in Review

Jefferies Group increased its Integra LifeSciences (IART) stake by 124% in Q3 2022, buying an estimated $157K and bringing the position to 5,511 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Jefferies Group first reported a position in IART in Q3 2014 and has held it in 13 quarters since. The position peaked at $4.73M in Q1 2022. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

Jefferies Group held 5,511 shares of Integra LifeSciences worth $233K as of Q3 2022.
Jefferies Group bought 3,055 Integra LifeSciences shares in Q3 2022, an estimated $157K.
Integra LifeSciences made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1321 holding.
Jefferies Group first reported a position in Integra LifeSciences in Q3 2014 and has held it in 13 quarters since.
Jefferies Group's Integra LifeSciences position peaked at $4.73M in Q1 2022.
282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.